Related Experiment Video
Updated: Oct 26, 2025

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
Published on: April 4, 2019
Burden of Respiratory Syncytial Virus Associated Severe Pneumonia in Hospitalized Children
Madhusha Gonapaladeniya1, Thushari Dissanayake1, Guwani Liyanage2
1Department of Microbiology, Faculty of Medical Sciences, University of Sri Jayewardenepura, Sri Lanka.
Insights
Respiratory syncytial virus (RSV) is a common cause of severe pneumonia in young children. Younger age, crowded homes, and lower C-reactive protein predict severe RSV pneumonia.
Area of Science:
- Pediatrics
- Infectious Diseases
- Virology
Background:
- Respiratory syncytial virus (RSV) is a significant pathogen causing severe respiratory illness globally.
- Community-acquired pneumonia (CAP) in children represents a substantial public health burden, particularly in low-resource settings.
Purpose of the Study:
- To determine the prevalence of RSV in severe pediatric CAP.
- To identify clinical, sociodemographic, and laboratory predictors of RSV etiology in hospitalized children.
Main Methods:
- A prospective hospital-based study enrolled 108 children under five with severe or very severe pneumonia.
- Nasopharyngeal secretions were analyzed for 19 viruses using multiplex RT-PCR.
- Univariate and multivariate analyses identified factors associated with RSV infection.
Main Results:
- RSV was detected in 42.6% of children with severe pneumonia.
- RSV was the most frequent viral cause, identified as a single pathogen in 41.3% of RSV-positive cases.
- Younger age, lower C-reactive protein levels, and household crowding were significantly associated with RSV-positive pneumonia.
Conclusions:
- RSV is the predominant viral agent in severe community-acquired pneumonia among children under five in Sri Lanka.
- Predictors for severe RSV-associated pneumonia include younger age, crowded housing conditions, and lower C-reactive protein levels.
- These findings can aid in early diagnosis and targeted interventions for RSV in pediatric populations.
Abstract:
Respiratory syncytial virus (RSV) is a leading cause of severe respiratory infections. We examined the burden of RSV-associated severe community-acquired pneumonia among hospitalized children and factors that predict RSV etiology. A hospital-based prospective study examined children below five years of age admitted with radiologically confirmed severe or very severe pneumonia in two tertiary care centers in Sri Lanka. Nasopharyngeal secretions (NPS) were tested for 19 viruses by multiplex RT-PCR. Univariate and multivariate analysis was performed to determine whether RSV etiology could be predicted based on clinical, sociodemographic, environmental, radiological, and laboratory parameters. A total of 108 children with severe or very severe were included in the study. At least one virus was found in NPS in 92.5% of children. Forty-six children had RSV (+) pneumonia. Mean RSV proportion was 42.6% (95% CI: 33.1-52.5%, p value = 0.149). RSV as a single virus was found in 41.3% (19/46). The children with RSV (+) pneumonia were younger (p = 0.026) and had lower C-reactive protein (p = 0.003) and household crowding (p = 0.012) than the RSV (-) group, after controlling for confounding covariates. In conclusion, the present study demonstrated that respiratory syncytial virus was the commonest virus associated with CAP in children under five years. Younger age, crowded housing, and lower C-reactive protein levels were predictors of severe RSV-associated pneumonia.
More Related Videos
09:14An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....